医学
汽车T细胞治疗
多发性骨髓瘤
癌症研究
抗原
细胞疗法
肿瘤科
耐火材料(行星科学)
免疫学
T细胞
嵌合抗原受体
细胞
生物
免疫系统
遗传学
天体生物学
作者
Noopur Raje,Jesús G. Berdeja,Yi Lin,David S. Siegel,Sundar Jagannath,Deepu Madduri,Michaela Liedtke,Jacalyn Rosenblatt,Marcela V. Maus,Ashley Turka,Lyh-Ping Lam,Richard A. Morgan,Kevin M. Friedman,Monica Massaro,Julie Wang,Greg Russotti,Zhihong Yang,Timothy Campbell,Kristen Hege,Fabio Petrocca
标识
DOI:10.1056/nejmoa1817226
摘要
Preclinical studies suggest that bb2121, a chimeric antigen receptor (CAR) T-cell therapy that targets B-cell maturation antigen (BCMA), has potential for the treatment of multiple myeloma.
科研通智能强力驱动
Strongly Powered by AbleSci AI